View all trials
Showing 17 results

The table can be sorted by “Study title” or “Protocol ID” sorted alphabetically in either Ascending (default) or Descending (on second click) order.
The default sorting is by “Study title” in alphabetical ascending order.

Study titleProtocol IDDisease type(s)Location(s)Eligibility criteriaStatus
12
 Page 1 of 2, items 1 to 10 of 17.
A Children's Oncology Group Protocol for Collecting and Banking Relapsed Acute Lymphoblastic Leukemia Research Specimens AALL05B1
Leukaemia
Leukaemia
Other Leukaemia
Princess Margaret HospitalPerth
Open
A clinical trial of donor-derived WT1 specific T cells for prevention of relapse in combination with multiple pathogen specific T cells for prevention of infection in patients undergoing allogeneic haemopoietic stem cell transplant for acute myeloid leukaemia INTACT-WT1
Leukaemia
AML
Children's Hospital at WestmeadSydney
Open
A Phase III Randomized Trial for Patients with de novo AML using Bortezomib (IND#58443, NSC# 681239) and Sorafenib (BAY 43-9006, IND#69896, NSC#724772) for Patients with High Allelic Ratio FLT3/ITD AAML1031
Leukaemia
AML
Children's Hospital at WestmeadSydney
Lady Cilento Children's HospitalBrisbane
Princess Margaret HospitalPerth
Royal Children's Hospital Melbourne
Sydney Children's Hospital
Open
A pilot study to test the feasibility, safety and efficacy of the addition of the BiTE antibody Blinatumomab to the Interfant-06 backbone in infants with MLL-rearranged acute lymphoblastic leukemia (A collaborative study of the Interfant network) BlinFant (NL59901.078.17)
Leukaemia
ALL
Children's Hospital at WestmeadSydney
Lady Cilento Children's HospitalBrisbane
Royal Children's Hospital Melbourne
Open
AALL08B1:Classification of Newly Diagnosed Acute Lymphoblastic Leukemia (ALL) AALL08B1
Leukaemia
Lady Cilento Children's HospitalBrisbane
Monash Children's HospitalMelbourne
Princess Margaret HospitalPerth
Royal Children's Hospital Melbourne
Open
AALL0932: Treatment of Patients with Newly Diagnosed Standard Risk B-Precursor Acute Lymphoblastic Leukemia (ALL) AALL0932
Leukaemia
Lady Cilento Children's HospitalBrisbane
Monash Children's HospitalMelbourne
Princess Margaret HospitalPerth
Royal Children's Hospital Melbourne
Open
AALL1231, A Phase III Randomized Trial Investigating Bortezomib (NSC# 681239; IND# 58443) on a Modified Augmented BFM (ABFM) Backbone in Newly Diagnosed TLymphoblastic Leukemia (T-ALL) and T-Lymphoblastic Lymphoma (T-LLY) AALL1231
Leukaemia
Lymphoma
Children's Hospital at WestmeadSydney
John Hunter Children's HospitalNewcastle
Lady Cilento Children's HospitalBrisbane
Royal Children's Hospital Melbourne
Open
Biology Study of Transient Myeloproliferative Disorder (TMD) in Children with Down Syndrome (DS) AAML08B1
Leukaemia
AML
Monash Children's HospitalMelbourne
Princess Margaret HospitalPerth
Royal Children's Hospital Melbourne
Open
International collaborative treatment protocol for children and adolescents with acute lymphoblastic leukemia AIEOP-BFM ALL 2009 Study 9
Leukaemia
Children's Hospital at WestmeadSydney
John Hunter Children's HospitalNewcastle
Sydney Children's Hospital
Women and Children's HospitalAdelaide
Open
International Collaborative Treatment Protocol for Infants Under One Year With Acute Lymphoblastic Leukaemia or Biphenotypic Leukaemia Interfant-06
Leukaemia
Children's Hospital at WestmeadSydney
John Hunter Children's HospitalNewcastle
Lady Cilento Children's HospitalBrisbane
Monash Children's HospitalMelbourne
Royal Children's Hospital Melbourne
Sydney Children's Hospital
Women and Children's HospitalAdelaide
Open